Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DMPA as Emergency Contraception
NCT03395756Phase 1Completed
- Sponsor
- University of Southern California
- Start
- Aug 2018
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of medroxyprogesterone acetate in contraception (3 arms), sponsored by University of Southern California. Primary endpoints: Ovulation, Ovulation Suppression and 1 more. Started Aug 2018; status: completed.
02
Drugs
medroxyprogesterone acetate
03
Conditions
contraception
Beyond the preview
Go deeper on NCT03395756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03395756.